DIAGNOS Announces Voting Results of Meeting of Shareholders
September 26, 2024 12:08 ET
|
DIAGNOS Inc.
BROSSARD, Quebec, Sept. 26, 2024 (GLOBE NEWSWIRE) -- DIAGNOS Inc. (“DIAGNOS” or the “Corporation”) (TSX Venture: ADK) (OTCQB: DGNOF), a pioneer in early detection of critical health issues through...
DIAGNOS Announces Variation in One Insider Ownership
September 23, 2024 16:29 ET
|
DIAGNOS Inc.
BROSSARD, Quebec, Sept. 23, 2024 (GLOBE NEWSWIRE) -- In accordance with regulatory requirements, Diagnos Inc. (“DIAGNOS”, the “Corporation” or the “Issuer”) (TSX Venture: ADK), announces that as a...
DIAGNOS Announces Closing of Private Placement
September 20, 2024 15:53 ET
|
DIAGNOS Inc.
BROSSARD, Quebec, Sept. 20, 2024 (GLOBE NEWSWIRE) -- DIAGNOS Inc. (“DIAGNOS” or the “Corporation”) (TSX Venture: ADK) (OTCQB: DGNOF), a pioneer in early detection of critical health issues through...
DIAGNOS annonce la date de l’assemblée générale et extraordinaire des actionnaires
August 22, 2024 15:45 ET
|
DIAGNOS inc.
BROSSARD, Québec, 22 août 2024 (GLOBE NEWSWIRE) -- Diagnos inc. (« DIAGNOS » ou la « Société ») (Bourse de croissance TSX : ADK) (OTCQB : DGNOF), un pionnier dans la détection précoce de...
DIAGNOS Announces Date of Annual General and Special Meeting of Shareholders
August 22, 2024 15:45 ET
|
DIAGNOS Inc.
BROSSARD, Quebec, Aug. 22, 2024 (GLOBE NEWSWIRE) -- Diagnos Inc. (“DIAGNOS” or the “Corporation”) (TSX Venture: ADK) (OTCQB: DGNOF) a leader in early detection of critical health issues through the...
DIAGNOS complète avec succès l’audit ISO 13485 / PAUMM et reçoit sa certification pour aller de l'avant avec la FDA et Santé Canada
August 20, 2024 09:45 ET
|
DIAGNOS inc.
BROSSARD, Québec, 20 août 2024 (GLOBE NEWSWIRE) -- Diagnos Inc. (« DIAGNOS » ou la « Société ») (Bourse de croissance TSX : ADK) (OTCQB : DGNOF), un fournisseur de services de soins de...
DIAGNOS Successfully Completes ISO 13485 / MDSAP Audit and receives its certification to move forward with FDA and Health Canada
August 20, 2024 09:45 ET
|
DIAGNOS Inc.
BROSSARD, Quebec, Aug. 20, 2024 (GLOBE NEWSWIRE) -- Diagnos Inc. (“DIAGNOS” or the “Corporation”) (TSX Venture: ADK) (OTCQB: DGNOF) a leader in early detection of critical health issues through the...
DIAGNOS Announces Closing of Second and Final Tranche of Private Placement
June 05, 2024 17:07 ET
|
DIAGNOS Inc.
BROSSARD, Quebec, June 05, 2024 (GLOBE NEWSWIRE) -- DIAGNOS Inc. (“DIAGNOS” or the “Corporation”) (TSX Venture: ADK) (OTCQB: DGNOF), a pioneer in early detection of critical health issues through...
DIAGNOS célèbre le lancement du nouveau service de dépistage de la rétinopathie diabétique de Labtician en Ontario et renouvelle son entente de distribution
May 21, 2024 09:00 ET
|
DIAGNOS inc.
BROSSARD, Québec, 21 mai 2024 (GLOBE NEWSWIRE) -- Diagnos inc. (« DIAGNOS » ou la « Société ») (Bourse de croissance TSX : ADK) (OTCQB : DGNOF), un pionnier dans la détection précoce de...
DIAGNOS celebrates the launch of Labtician’s new screening service for diabetic retinopathy in Ontario and renews its distribution agreement
May 21, 2024 09:00 ET
|
DIAGNOS Inc.
BROSSARD, Quebec, May 21, 2024 (GLOBE NEWSWIRE) -- DIAGNOS Inc. (“DIAGNOS” or the “Corporation”) (TSX Venture: ADK) (OTCQB: DGNOF), a pioneer in early detection of critical health issues through its...